chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Nipple pain, Pruritus
Clinical narrative: Lots of itching in the right breast; Underneath the nipple it got a little hard; Underneath the breast itchy time to time; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Lots of itching in the right breast), NIPPLE PAIN (Underneath the nipple it got a little hard) and PRURITUS (Underneath the breast itchy time to time) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced PRURITUS (Lots of itching in the right breast), NIPPLE PAIN (Underneath the nipple it got a little hard) and PRURITUS (Underneath the breast itchy time to time). At the time of the report, PRURITUS (Lots of itching in the right breast), NIPPLE PAIN (Underneath the nipple it got a little hard) and PRURITUS (Underneath the breast itchy time to time) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Abnormal dreams, Arthralgia, Body temperature, Fatigue
Clinical narrative: I was suppose to get my second shot in march; Headache above eyes; Muscle Pain; Joint Pain; Fever 101 F; Fatigue; Nausea; creepiness in the Stomach; Insomnia; Annoying dreams; Aches in the back of head and Neck; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (creepiness in the Stomach), INSOMNIA (Insomnia), ABNORMAL DREAMS (Annoying dreams), PAIN (Aches in the back of head and Neck) and PRODUCT DOSE OMISSION ISSUE (I was suppose to get my second shot in march) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced ABDOMINAL DISCOMFORT (creepiness in the Stomach), INSOMNIA (Insomnia), ABNORMAL DREAMS (Annoying dreams), PAIN (Aches in the back of head and Neck), HEADACHE (Headache above eyes), MYALGIA (Muscle Pain), ARTHRALGIA (Joint Pain), PYREXIA (Fever 101 F), FATIGUE (Fatigue) and NAUSEA (Nausea). On 09-Jul-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (I was suppose to get my second shot in march). On 17-Feb-2021, ABDOMINAL DISCOMFORT (creepiness in the Stomach), INSOMNIA (Insomnia), ABNORMAL DREAMS (Annoying dreams), HEADACHE (Headache above eyes), PYREXIA (Fever 101 F), FATIGUE (Fatigue) and NAUSEA (Nausea) had resolved. At the time of the report, PAIN (Aches in the back of head and Neck), PRODUCT DOSE OMISSION ISSUE (I was suppose to get my second shot in march), MYALGIA (Muscle Pain) and ARTHRALGIA (Joint Pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 f High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant medications was not provided. Treatment information not provided.    Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Significant Follow up document attached. Added new event. Denied consent for follow up
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Insomnia, Myalgia, Nausea, Pain
Clinical narrative: I was suppose to get my second shot in march; Headache above eyes; Muscle Pain; Joint Pain; Fever 101 F; Fatigue; Nausea; creepiness in the Stomach; Insomnia; Annoying dreams; Aches in the back of head and Neck; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (creepiness in the Stomach), INSOMNIA (Insomnia), ABNORMAL DREAMS (Annoying dreams), PAIN (Aches in the back of head and Neck) and PRODUCT DOSE OMISSION ISSUE (I was suppose to get my second shot in march) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced ABDOMINAL DISCOMFORT (creepiness in the Stomach), INSOMNIA (Insomnia), ABNORMAL DREAMS (Annoying dreams), PAIN (Aches in the back of head and Neck), HEADACHE (Headache above eyes), MYALGIA (Muscle Pain), ARTHRALGIA (Joint Pain), PYREXIA (Fever 101 F), FATIGUE (Fatigue) and NAUSEA (Nausea). On 09-Jul-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (I was suppose to get my second shot in march). On 17-Feb-2021, ABDOMINAL DISCOMFORT (creepiness in the Stomach), INSOMNIA (Insomnia), ABNORMAL DREAMS (Annoying dreams), HEADACHE (Headache above eyes), PYREXIA (Fever 101 F), FATIGUE (Fatigue) and NAUSEA (Nausea) had resolved. At the time of the report, PAIN (Aches in the back of head and Neck), PRODUCT DOSE OMISSION ISSUE (I was suppose to get my second shot in march), MYALGIA (Muscle Pain) and ARTHRALGIA (Joint Pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 f High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant medications was not provided. Treatment information not provided.    Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Significant Follow up document attached. Added new event. Denied consent for follow up
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue, Pyrexia
Clinical narrative: I was suppose to get my second shot in march; Headache above eyes; Muscle Pain; Joint Pain; Fever 101 F; Fatigue; Nausea; creepiness in the Stomach; Insomnia; Annoying dreams; Aches in the back of head and Neck; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (creepiness in the Stomach), INSOMNIA (Insomnia), ABNORMAL DREAMS (Annoying dreams), PAIN (Aches in the back of head and Neck) and PRODUCT DOSE OMISSION ISSUE (I was suppose to get my second shot in march) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced ABDOMINAL DISCOMFORT (creepiness in the Stomach), INSOMNIA (Insomnia), ABNORMAL DREAMS (Annoying dreams), PAIN (Aches in the back of head and Neck), HEADACHE (Headache above eyes), MYALGIA (Muscle Pain), ARTHRALGIA (Joint Pain), PYREXIA (Fever 101 F), FATIGUE (Fatigue) and NAUSEA (Nausea). On 09-Jul-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (I was suppose to get my second shot in march). On 17-Feb-2021, ABDOMINAL DISCOMFORT (creepiness in the Stomach), INSOMNIA (Insomnia), ABNORMAL DREAMS (Annoying dreams), HEADACHE (Headache above eyes), PYREXIA (Fever 101 F), FATIGUE (Fatigue) and NAUSEA (Nausea) had resolved. At the time of the report, PAIN (Aches in the back of head and Neck), PRODUCT DOSE OMISSION ISSUE (I was suppose to get my second shot in march), MYALGIA (Muscle Pain) and ARTHRALGIA (Joint Pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 f High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant medications was not provided. Treatment information not provided.    Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Significant Follow up document attached. Added new event. Denied consent for follow up
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Insomnia
Clinical narrative: shortness of breath,short of breath when he is walking around today; trouble sleeping; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath,short of breath when he is walking around today) and INSOMNIA (trouble sleeping) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes and Hypertension. Concomitant products included METFORMIN, INSULIN, PANTOPRAZOLE, ENALAPRIL, FAMOTIDINE, DILTIAZEM and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced DYSPNOEA (shortness of breath,short of breath when he is walking around today) and INSOMNIA (trouble sleeping). At the time of the report, DYSPNOEA (shortness of breath,short of breath when he is walking around today) and INSOMNIA (trouble sleeping) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        No treatment information was provided.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site mass, Injection site nodule, Injection site swelling, Pain in extremity, Vaccination site erythema
Clinical narrative: injection site was swollen; injection site was firm; knot at the injection site; red line across the injection site; itches; pain in arm; A spontaneous report was received from a consumer concerning a 58-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced pain in arm, injection site was swollen, injection site was firm, knot at the injection site, red line across the injection site and had itches.  The patient's medical history included that she was allergic to antibiotics, lactose, gluten and oats. she had a previous medical history of Hypogammaglobinemia. Concomitant medications reported were Mucinex for drug use for unknown indication.  On 9 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 013MZ0A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 9 Feb 2021, the patient experienced pain in arm (pain in extremities), injection site was swollen(injection site swelling), injection site was firm (injection site mass), knot at the injection site (injection site nodules) and red line across the injection site (injection site redness) and  itches (injection site pruritus).  Treatment details was not reported.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events was unknown..
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: injection site was swollen; injection site was firm; knot at the injection site; red line across the injection site; itches; pain in arm; A spontaneous report was received from a consumer concerning a 58-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced pain in arm, injection site was swollen, injection site was firm, knot at the injection site, red line across the injection site and had itches.  The patient's medical history included that she was allergic to antibiotics, lactose, gluten and oats. she had a previous medical history of Hypogammaglobinemia. Concomitant medications reported were Mucinex for drug use for unknown indication.  On 9 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 013MZ0A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 9 Feb 2021, the patient experienced pain in arm (pain in extremities), injection site was swollen(injection site swelling), injection site was firm (injection site mass), knot at the injection site (injection site nodules) and red line across the injection site (injection site redness) and  itches (injection site pruritus).  Treatment details was not reported.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events was unknown..
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: Fever of of 102; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of of 102) and NAUSEA (Nausea) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced PYREXIA (Fever of of 102) and NAUSEA (Nausea). At the time of the report, PYREXIA (Fever of of 102) and NAUSEA (Nausea) outcome was unknown. Not Provided          No relevant concomitant medications were reported. Treatment details included Advil.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Vomiting
Clinical narrative: Diarrhea; Chills clammy; Vomit; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), CHILLS (Chills clammy) and VOMITING (Vomit) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced DIARRHOEA (Diarrhea), CHILLS (Chills clammy) and VOMITING (Vomit). At the time of the report, DIARRHOEA (Diarrhea), CHILLS (Chills clammy) and VOMITING (Vomit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported  Treatment details not provided.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore Arm) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 025J20-2A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL + HIDROCLOROTIAZIDA), LEVOTHYROXINE, ATORVASTATIN, ANASTROZOLE, HYDROCODONE and NABUMETONE for an unknown indication.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore Arm). At the time of the report, PAIN IN EXTREMITY (Sore Arm) outcome was unknown.            The patient did not receive any treatment.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Eating disorder symptom, Hypopnoea, Pyrexia
Clinical narrative: lack of taste; lack of smell; fever; troubled breathing (shallow); trouble eating; A Spontaneous case  was received from consumer, concerning a female patient  of age 70, who received Moderna's COVID-19 vaccine experienced Ageusia/ lack of taste, Anosmia/ lack of smell, Pyrexia/ fever, Hypopnoea/ troubled breathing (shallow), Eating disorder symptom / trouble eating.   The patient's medical history was not provided. The Patient's concomitant medications were not provided.  On an unknown date, prior to the onset of events, the patient received her first of two planned doses of mRNA-1273 (Batch number : unknown) via unspecified route for COVID-19 infection prophylaxis  On 27Feb2021, prior to the onset of events, the patient received her second of two planned doses of mRNA-1273 (Batch number : unknown) via unspecified route for COVID-19 infection prophylaxis.  On 29Feb2021, the patient is experiencing lack of smell, taste, fever, trouble eating and trouble breathing (shallow). Oximeter reads that she is receiving enough oxygen (no specific percentage).  As the patient has already taken both the scheduled doses of the vaccine, the action taken in response to the events, Ageusia, Anosmia, Pyrexia, Hypopnoea, Eating disorder symptom was unknown.  The outcome of the event Ageusia, Anosmia, Pyrexia, Hypopnoea , Eating disorder symptom was considered to be unknown.  The treatment medications taken by the patient was aspirin.
Sex: F
Vaccine: COVID19
Symptoms: Glossodynia, Heart rate increased, Pyrexia, Tongue discomfort
Clinical narrative: fast heartbeat at night intermittently since receiving dose 2; Tongue felt like it was burning; Sore on the tongue; Light fever; This spontaneous case was reported by a consumer and describes the occurrence of TONGUE DISCOMFORT (Tongue felt like it was burning), GLOSSODYNIA (Sore on the tongue), HEART RATE INCREASED (fast heartbeat at night intermittently since receiving dose 2) and PYREXIA (Light fever) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 012L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced PYREXIA (Light fever). On 13-Feb-2021, the patient experienced TONGUE DISCOMFORT (Tongue felt like it was burning) and GLOSSODYNIA (Sore on the tongue). On an unknown date, the patient experienced HEART RATE INCREASED (fast heartbeat at night intermittently since receiving dose 2). On 11-Feb-2021, PYREXIA (Light fever) had resolved. At the time of the report, TONGUE DISCOMFORT (Tongue felt like it was burning) and GLOSSODYNIA (Sore on the tongue) had resolved and HEART RATE INCREASED (fast heartbeat at night intermittently since receiving dose 2) outcome was unknown.            Concomitant medications were not provided. Treatment information was not reported.    This case was linked to MOD21-031476 (Patient Link).
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pyrexia
Clinical narrative: Chills; Fever 101.6 degree F; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and PYREXIA (Fever 101.6 degree F) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history provided).    On 14-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced CHILLS (Chills) and PYREXIA (Fever 101.6 degree F). At the time of the report, CHILLS (Chills) and PYREXIA (Fever 101.6 degree F) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jan-2021, Body temperature: 101.6 (Inconclusive) Fever 101.6 degree F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Injection site warmth, Vaccination site erythema, Vaccination site swelling
Clinical narrative: feverish at the spot; Right arm swelled up, it is about 2.5 inches in diameter, is hard; red at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (feverish at the spot), VACCINATION SITE SWELLING (Right arm swelled up, it is about 2.5 inches in diameter, is hard) and VACCINATION SITE ERYTHEMA (red at the injection site) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced INJECTION SITE WARMTH (feverish at the spot), VACCINATION SITE SWELLING (Right arm swelled up, it is about 2.5 inches in diameter, is hard) and VACCINATION SITE ERYTHEMA (red at the injection site). At the time of the report, INJECTION SITE WARMTH (feverish at the spot), VACCINATION SITE SWELLING (Right arm swelled up, it is about 2.5 inches in diameter, is hard) and VACCINATION SITE ERYTHEMA (red at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Suspected COVID-19
Clinical narrative: developed symptoms of covid; This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (developed symptoms of covid) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced SUSPECTED COVID-19 (developed symptoms of covid). The patient was treated with GUAIFENESIN (MUCINEX) at an unspecified dose and frequency. At the time of the report, SUSPECTED COVID-19 (developed symptoms of covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Feb-2021, SARS-CoV-2 test (positive-negative): positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment details included musinax, deliquel.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Pyrexia
Clinical narrative: Headache; Muscle ache; Chills; temperature; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), MYALGIA (Muscle ache), CHILLS (Chills) and PYREXIA (temperature) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included Blood thinners and Medication for diabetes for an unknown indication.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache), MYALGIA (Muscle ache), CHILLS (Chills) and PYREXIA (temperature). At the time of the report, HEADACHE (Headache), MYALGIA (Muscle ache), CHILLS (Chills) and PYREXIA (temperature) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Dry skin, Herpes zoster, Pain
Clinical narrative: diagnosed this morning with shingles; pain is mild; dry skin in a circle 6 inches below the injection site; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (diagnosed this morning with shingles), DRY SKIN (dry skin in a circle 6 inches below the injection site) and PAIN (pain is mild) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     The patient's past medical history included Ulcerative colitis (had to have a large bowel removal due to that.), COVID-19 in November 2020 and Immune system disorder (NOS) (Immune health issues). Concomitant products included LOPERAMIDE HYDROCHLORIDE (LOMOTIL [LOPERAMIDE HYDROCHLORIDE]), FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF) and ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL (EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;PARACETAMOL]) for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced DRY SKIN (dry skin in a circle 6 inches below the injection site). On 17-Feb-2021, the patient experienced HERPES ZOSTER (diagnosed this morning with shingles) and PAIN (pain is mild). The patient was treated with VALACICLOVIR HYDROCHLORIDE (VALTREX) at an unspecified dose and frequency and GABAPENTIN at an unspecified dose and frequency. At the time of the report, HERPES ZOSTER (diagnosed this morning with shingles) and PAIN (pain is mild) outcome was unknown and DRY SKIN (dry skin in a circle 6 inches below the injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications reported also included Nasotine for drug use for unknown indication.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Pt reaction to the vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of VACCINATION COMPLICATION (Pt reaction to the vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Pt reaction to the vaccine). At the time of the report, VACCINATION COMPLICATION (Pt reaction to the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Infection
Clinical narrative: Got an infection after being vaccinated; This spontaneous case was reported by a consumer and describes the occurrence of INFECTION (Got an infection after being vaccinated) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced INFECTION (Got an infection after being vaccinated). At the time of the report, INFECTION (Got an infection after being vaccinated) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Photosensitivity reaction, Pruritus, Rash, Sticky skin
Clinical narrative: I have developed a rash in my arm and it seems to be sticking around; pink; The site started itching; rash; This spontaneous case was reported by a consumer and describes the occurrence of STICKY SKIN (I have developed a rash in my arm and it seems to be sticking around), PHOTOSENSITIVITY REACTION (pink), PRURITUS (The site started itching) and RASH (rash) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced STICKY SKIN (I have developed a rash in my arm and it seems to be sticking around), PHOTOSENSITIVITY REACTION (pink), PRURITUS (The site started itching) and RASH (rash). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, STICKY SKIN (I have developed a rash in my arm and it seems to be sticking around), PHOTOSENSITIVITY REACTION (pink), PRURITUS (The site started itching) and RASH (rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 09-Feb-2021: No specific follow-up information recorded.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, COVID-19
Clinical narrative: tested positive for covid; This spontaneous case was reported by a nurse and describes the occurrence of COVID-19 (tested positive for covid) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included SLE.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 Year. On 23-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Jan-2021, the patient experienced COVID-19 (tested positive for covid). At the time of the report, COVID-19 (tested positive for covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Jan-2021, Body temperature: 101.6-103.2 (High) Fever.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.    This case was linked to MOD-2021-028818 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  MOD-2021-028818:Mother
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: redness below the injection site; Swelling below the injection site (an inch and a half below the injection site); Yesterday it developed itching; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Yesterday it developed itching), VACCINATION SITE ERYTHEMA (redness below the injection site) and VACCINATION SITE SWELLING (Swelling below the injection site (an inch and a half below the injection site)) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     Concomitant products included VITAMIN D [VITAMIN D NOS], ESTRADIOL, NORGESTIMATE (PREFEST), PANTOPRAZOLE SODIUM SESQUIHYDRATE (PROTONIX [PANTOPRAZOLE SODIUM SESQUIHYDRATE]), ACETYLSALICYLIC ACID (BABY ASPIRIN), NEBIVOLOL HYDROCHLORIDE (BYSTOLIC), MONTELUKAST SODIUM (SINGULAIR), FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) and IPRATROPIUM BROMIDE for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Yesterday it developed itching). On 06-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness below the injection site) and VACCINATION SITE SWELLING (Swelling below the injection site (an inch and a half below the injection site)). At the time of the report, VACCINATION SITE PRURITUS (Yesterday it developed itching) had resolved and VACCINATION SITE ERYTHEMA (redness below the injection site) and VACCINATION SITE SWELLING (Swelling below the injection site (an inch and a half below the injection site)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment taken or applied she just put ice on it.
Age: 69.0
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Nausea
Clinical narrative: nausea; chills; headache; joint pain; fatigue; A spontaneous report was received from a consumer concerning a 69-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events chills, headache, joint pain, nausea, fatigue.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 21 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 029L20A) intramuscularly for prophylaxis of COVID-19 infection.  On 21 Jan 2021, the patient experienced fatigue. \On 25 Jan 2021, the patient experienced chills, headache and joint pain. On 26 Jan 2021, the patient experienced nausea.  Treatment details was not provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event nausea was considered resolved on 26 Jan 2021.The outcome of events- joint pain and chills-was considered to be resolved on 27 Jan 2021. Headache was considered to be resolved on 28 Jan 2021.The outcome of event-fatigue was considered to be resolved on 29 Jan 2021.
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: swelling Lymph nodes in her left arm; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (swelling Lymph nodes in her left arm) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for an unknown indication.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (swelling Lymph nodes in her left arm). At the time of the report, LYMPHADENOPATHY (swelling Lymph nodes in her left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site bruising, Vaccination site erythema, Vaccination site haemorrhage, Vaccination site swelling
Clinical narrative: bleeding at the injection site; swelling at the injection site; bruising at the injection site; skin was pink where the band aid adhesive was; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HAEMORRHAGE (bleeding at the injection site), VACCINATION SITE SWELLING (swelling at the injection site), VACCINATION SITE BRUISING (bruising at the injection site) and VACCINATION SITE ERYTHEMA (skin was pink where the band aid adhesive was) in a 65-year-old not specif patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced VACCINATION SITE HAEMORRHAGE (bleeding at the injection site), VACCINATION SITE SWELLING (swelling at the injection site), VACCINATION SITE BRUISING (bruising at the injection site) and VACCINATION SITE ERYTHEMA (skin was pink where the band aid adhesive was). At the time of the report, VACCINATION SITE HAEMORRHAGE (bleeding at the injection site), VACCINATION SITE SWELLING (swelling at the injection site), VACCINATION SITE BRUISING (bruising at the injection site) and VACCINATION SITE ERYTHEMA (skin was pink where the band aid adhesive was) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot
Clinical narrative: arm got hot after second dose; arm got red after second dose; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (arm got hot after second dose) and ERYTHEMA (arm got red after second dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On 21-Feb-2021, the patient experienced ERYTHEMA (arm got red after second dose). On an unknown date, the patient experienced FEELING HOT (arm got hot after second dose). The patient was treated with CORTISONE for Adverse event, at a dose of unk, CREAM. At the time of the report, FEELING HOT (arm got hot after second dose) and ERYTHEMA (arm got red after second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment medication of the patient included - Aloe and Moisturizer.
Sex: U
Vaccine: COVID19
Symptoms: Toothache
Clinical narrative: Someone's teeth were hurting; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of TOOTHACHE (Someone's teeth were hurting) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced TOOTHACHE (Someone's teeth were hurting). At the time of the report, TOOTHACHE (Someone's teeth were hurting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: U
Vaccine: COVID19
Symptoms: Dizziness, Pain in extremity, SARS-CoV-2 antibody test negative
Clinical narrative: Arm pain; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain) and DIZZINESS (Dizziness) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 1. On 08-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm pain) and DIZZINESS (Dizziness). At the time of the report, PAIN IN EXTREMITY (Arm pain) and DIZZINESS (Dizziness) was resolving. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jan-2021, SARS-CoV-2 antibody test negative: negative negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: slight soreness in both the doses; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (slight soreness in both the doses) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No Medical History information was reported.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (slight soreness in both the doses). At the time of the report, VACCINATION SITE PAIN (slight soreness in both the doses) outcome was unknown.            Concomitant medications were not provided.  Action taken with the drug in response to the events was not applicable.   This case was linked to MOD-2021-029681 (Patient Link).
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Irritability, Vaccination site pain
Clinical narrative: slight soreness in both the doses; Little annoying but nothing else; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (slight soreness in both the doses) and IRRITABILITY (Little annoying but nothing else) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (slight soreness in both the doses) and IRRITABILITY (Little annoying but nothing else). At the time of the report, VACCINATION SITE PAIN (slight soreness in both the doses) and IRRITABILITY (Little annoying but nothing else) outcome was unknown.            No treatment information was provided. No relevant concomitant medications reported.   This case was linked to MOD-2021-029670 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site pruritus, Vaccination site reaction, Vaccination site swelling
Clinical narrative: Itchiness; Seemed like a severe bee sting; Very large,swelling; Sore/painful; Normal side effects at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Normal side effects at the injection site), VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE PAIN (Seemed like a severe bee sting), VACCINATION SITE SWELLING (Very large,swelling) and VACCINATION SITE PAIN (Sore/painful) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced VACCINATION SITE REACTION (Normal side effects at the injection site). On 10-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE PAIN (Seemed like a severe bee sting), VACCINATION SITE SWELLING (Very large,swelling) and VACCINATION SITE PAIN (Sore/painful). On 05-Feb-2021, VACCINATION SITE REACTION (Normal side effects at the injection site) had resolved. At the time of the report, VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE PAIN (Seemed like a severe bee sting), VACCINATION SITE SWELLING (Very large,swelling) and VACCINATION SITE PAIN (Sore/painful) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus
Clinical narrative: itching at injection site; redness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (itching at injection site) and INJECTION SITE ERYTHEMA (redness at injection site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced INJECTION SITE PRURITUS (itching at injection site) and INJECTION SITE ERYTHEMA (redness at injection site). At the time of the report, INJECTION SITE PRURITUS (itching at injection site) and INJECTION SITE ERYTHEMA (redness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided. No relevant concomitant medications reported.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: COVID arm that has been present for 12 days; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (COVID arm that has been present for 12 days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (COVID arm that has been present for 12 days). At the time of the report, VACCINATION SITE REACTION (COVID arm that has been present for 12 days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic, Urticaria
Clinical narrative: Rash is not always visIble, it comes and goes, it's like a hives, little hive types under the skin; Itchy rash; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Rash is not always visIble, it comes and goes, it's like a hives, little hive types under the skin) and RASH PRURITIC (Itchy rash) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URTICARIA (Rash is not always visIble, it comes and goes, it's like a hives, little hive types under the skin) and RASH PRURITIC (Itchy rash). The patient was treated with TRIAMCINOLONE ACETONIDE for Itchy rash and Urticarial rash, at a dose of 0.1 percent and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, URTICARIA (Rash is not always visIble, it comes and goes, it's like a hives, little hive types under the skin) and RASH PRURITIC (Itchy rash) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Treatment information not provided by reporter.   This case was linked to MOD-2021-029805 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 09-Jul-2021: Reporter's email info corrected
Sex: F
Vaccine: COVID19
Symptoms: Cough, SARS-CoV-2 test
Clinical narrative: Persistent cough; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Persistent cough) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Knee surgery NOS on 01-Feb-2021.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced COUGH (Persistent cough). The patient was treated with STEROIDS (oral) for Cough, at an unspecified dose and frequency. At the time of the report, COUGH (Persistent cough) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, SARS-CoV-2 test: NEGATIVE.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.